Core Viewpoint - The joint release of the "Medical Advertising Recognition Guidelines" by the State Administration for Market Regulation, the National Health Commission, and the National Administration of Traditional Chinese Medicine aims to combat misleading medical advertisements and clarify the responsibilities of medical institutions in advertising [1][2]. Group 1: Regulatory Measures - The guidelines strictly limit the publication of medical advertisements to legally established medical institutions, prohibiting any individual or entity from publishing medical advertisements independently or through others [2]. - The guidelines address the issue of misleading advertisements disguised as medical information or health education, specifying which forms of information disclosure and health education do not constitute advertisements, while also listing specific scenarios where such disclosures are misused [2]. - The guidelines establish institutional arrangements for the transfer of leads and situation reporting between market regulation departments and health authorities to effectively address the chaos in medical advertising [2]. Group 2: Enforcement Actions - In the first half of 2025, market regulation departments across the country handled 1,666 cases of illegal medical advertising, with fines totaling 12.78 million yuan [1]. - The State Administration for Market Regulation has publicly exposed 30 typical cases of illegal advertisements in three batches, covering various sectors including medical beauty and medical devices, creating a strong deterrent effect [1]. - The guidelines are part of a broader effort to enhance collaboration between market regulation departments and health authorities, establishing a regular mechanism for joint assessment and enforcement [2].
三部门发布《医疗广告认定指南》
Jing Ji Ri Bao·2025-08-13 22:07